PriceTargets.com logo

NASDAQ:PDEX - Pro-Dex Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$31.91 As of 01/25/2021 01:00 AM ET
▼ -0.49 (-1.51%)
1 month | 3 months | 12 months
Get New Pro-Dex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PDEX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PDEX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Pro-Dex in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $31.91.
N/A
The current consensus among 0 contributing investment analysts is to n/a stock in Pro-Dex. This rating has held steady since April 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/4/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/14/2019Ascendiant Capital MarketsSet Price TargetBuy$20.00Low
i
Rating by Ed Woo at Ascendiant Capital Markets
9/8/2017Ascendiant Capital MarketsReiterated RatingBuy$8.00 ➝ $9.00Low
i
1/4/2017Ascendiant Capital MarketsInitiated CoverageBuy$7.00N/A
i
(Data available from 1/25/2016 forward)
Pro-Dex logo
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $31.91
$31.35
$32.78

50 Day Range

MA: $34.51
$28.70
$42.60

52 Week Range

Now: $31.91
$12.83
$42.60

Volume

24,728 shs

Average Volume

30,229 shs

Market Capitalization

$123.20 million

P/E Ratio

26.97

Dividend Yield

N/A

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of Pro-Dex?

The following Wall Street analysts have issued research reports on Pro-Dex in the last twelve months: TheStreet.

What is the current price target for Pro-Dex?

0 Wall Street analysts have set twelve-month price targets for Pro-Dex in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Pro-Dex in the next year.

What is the current consensus analyst rating for Pro-Dex?

Pro-Dex currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."

What other companies compete with Pro-Dex?

Other companies that are similar to Pro-Dex include Invo Bioscience, SeaSpine, Accuray, TransEnterix, Retractable Technologies, Cytosorbents, Neuronetics, Apyx Medical, InfuSystem, ClearPoint Neuro, iCAD, UFP Technologies, Co-Diagnostics, Utah Medical Products and The Westaim.

How do I contact Pro-Dex's investor relations team?

Pro-Dex's physical mailing address is 2361 MCGAW AVENUE, IRVINE CA, 92614. The medical instruments supplier's listed phone number is 949-769-3200 and its investor relations email address is [email protected] The official website for Pro-Dex is www.pro-dex.com.